FGF1-gold nanoparticle conjugates targeting FGFR efficiently decrease cell viability upon NIR irradiation
Anna Szlachcic,1 Katarzyna Pala,1 Malgorzata Zakrzewska,1 Piotr Jakimowicz,1 Antoni Wiedlocha,2 Jacek Otlewski11Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Poland; 2Centre for Cancer Biomedicine, Department of Biochemistry, Institute for Cancer Research, The N...
Guardado en:
Autores principales: | Szlachcic A, Pala K, Zakrzewska M, Jakimowicz P, Wiedlocha A, Otlewski J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da0bcd057f58494da4762120e553c92c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
por: Jakub Szymczyk, et al.
Publicado: (2021) -
Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent
por: Karolina Jendryczko, et al.
Publicado: (2021) -
Anti-FGFR1 aptamer-tagged superparamagnetic conjugates for anticancer hyperthermia therapy
por: Jurek PM, et al.
Publicado: (2017) -
Antibody-induced dimerization of FGFR1 promotes receptor endocytosis independently of its kinase activity
por: Łukasz Opaliński, et al.
Publicado: (2017) -
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
por: Alexander Grabner, et al.
Publicado: (2017)